Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Interprofessional education and practice guide No. 9: Sustaining interprofessional simulation using change management principles.

Kumar A, Kent F, Wallace EM, McLelland G, Bentley D, Koutsoukos A, Nestel D.

J Interprof Care. 2018 Aug 30:1-8. doi: 10.1080/13561820.2018.1511525. [Epub ahead of print]

PMID:
30160555
2.

Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors.

Rosen LS, Kurzrock R, Mulay M, Van Vugt A, Purdom M, Ng C, Silverman J, Koutsoukos A, Sun YN, Bass MB, Xu RY, Polverino A, Wiezorek JS, Chang DD, Benjamin R, Herbst RS.

J Clin Oncol. 2007 Jun 10;25(17):2369-76.

PMID:
17557949
3.

An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the knee.

Strand V, Conaghan PG, Lohmander LS, Koutsoukos AD, Hurley FL, Bird H, Brooks P, Day R, Puhl W, Band PA.

Osteoarthritis Cartilage. 2006 Sep;14(9):859-66. Epub 2006 Apr 19.

4.

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.

McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Murphy S, Howard F 4th, Davis K, Lin JS, Metzel P, Corash L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG.

Blood. 2004 Sep 1;104(5):1534-41. Epub 2004 May 11.

5.

Quality control of oncology clinical trials.

Meyerson LJ, Wiens BL, LaVange LM, Koutsoukos AD.

Hematol Oncol Clin North Am. 2000 Aug;14(4):953-71, x. Review.

PMID:
10949783
6.
7.

Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of action.

Koutsoukos AD, Rubinstein LV, Faraggi D, Simon RM, Kalyandrug S, Weinstein JN, Kohn KW, Paull KD.

Stat Med. 1994 Mar 15-Apr 15;13(5-7):719-30.

PMID:
8023045
8.

Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's Drug Discovery Program for Cancer and AIDS.

Weinstein JN, Myers T, Buolamwini J, Raghavan K, van Osdol W, Licht J, Viswanadhan VN, Kohn KW, Rubinstein LV, Koutsoukos AD, et al.

Stem Cells. 1994 Jan;12(1):13-22.

PMID:
8142917
9.

Neural computing in cancer drug development: predicting mechanism of action.

Weinstein JN, Kohn KW, Grever MR, Viswanadhan VN, Rubinstein LV, Monks AP, Scudiero DA, Welch L, Koutsoukos AD, Chiausa AJ, et al.

Science. 1992 Oct 16;258(5081):447-51.

PMID:
1411538
10.

Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.

Wu L, Smythe AM, Stinson SF, Mullendore LA, Monks A, Scudiero DA, Paull KD, Koutsoukos AD, Rubinstein LV, Boyd MR, et al.

Cancer Res. 1992 Jun 1;52(11):3029-34.

11.

Artists' offspring.

Rubinstein LV, Koutsoukos AD.

Nature. 1992 May 14;357(6374):106. No abstract available.

PMID:
1579157
12.

Exploratory data analytic techniques to evaluate anticancer agents screened in a cell culture panel.

Hodes L, Paull K, Koutsoukos A, Rubinstein L.

J Biopharm Stat. 1992;2(1):31-48.

PMID:
1300204
13.

Tumor-like pulmonary manifestations of congestive heart failure.

Koutsoukos AG, Dontas AS.

Gerontol Clin (Basel). 1975;17(4):210-9.

PMID:
130280
14.

Use of disodium cromoglycate during the course of specific desensitizing treatment in asthmatic patients.

Koutsoukos AG.

Acta Allergol. 1973 May;28(1):62-7. No abstract available.

PMID:
4199888
15.

[Application of the two-dimensional immunoelectrophoresis technic to the problem of cirrhosis].

Rebeyrotte P, Baujat JP, Labbé JP, Koutsoukos A.

Pathol Biol (Paris). 1970 Jun-Jul;18(11):653-61. French. No abstract available.

PMID:
4914155
16.

[Technical modifications of the bidimensional immunoelectrophoresis method. Application to various biological fluids].

Rebeyrotte P, Labbe JP, Koutsoukos A.

Ann Biol Clin (Paris). 1970;28(2):153-8. French. No abstract available.

PMID:
4194881
17.

A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients.

Benos SA, Koutsoukos A, Sotirakis I, Pavlatos FC.

Acta Allergol. 1969 Sep;24(3):178-86. No abstract available.

PMID:
4314190
18.

A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. I. Adrenocorticotropic and pituitary responsiveness following long-term intermittent administration.

Benos SA, Koutsoukos A, Braouzi H, Georgopoulos A, Pavlatos FC.

Acta Allergol. 1969 Sep;24(3):165-77. No abstract available.

PMID:
4314189
19.

[Modifications of Laurell quantitative immunoelectrophoresis method. Demonstration of gamma-globulins].

Rebeyrotte P, Koutsoukos A, Labbé JP.

C R Acad Sci Hebd Seances Acad Sci D. 1969;269(4):531-4. French. No abstract available.

PMID:
4186532

Supplemental Content

Loading ...
Support Center